Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.

Coukos, Alexander; Vionnet, Julien; Sempoux, Christine; Fraga, Montserrat

Coukos, Alexander; Vionnet, Julien; Sempoux, Christine; Fraga, Montserrat.

Afiliação

Coukos A; Service of Gastroenterology and Hepatology, Lausanne University Hospital, Lausanne, Switzerland alexcoukos@gmail.com.
Vionnet J; Service of Gastroenterology and Hepatology, Lausanne University Hospital, Lausanne, Switzerland.
Sempoux C; Transplantation Center, Lausanne University Hospital, Lausanne, Switzerland.
Fraga M; Department of pathology, Lausanne University Hospital, Lausanne, Switzerland.

J Immunother Cancer ; 11(2)2023 02.

Article em En | MEDLINE | ID: mdl-36849203

Assuntos

Colangite; Inibidores de Checkpoint Imunológico; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Colangite/induzido quimicamente

Palavras-chave

Autoimmunity; CTLA-4 Antigen; Cytotoxicity, Immunologic; Immunotherapy; Programmed Cell Death 1 Receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangite / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangite / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2023 Tipo de documento: Article